| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |